The entire medical system of the United States has been focused on a single threat over the past eight weeks. While the dangers from COVID-19 remain present, many states are beginning to open back up, and as capacity increases, medical facilities are easing back into seeing patients. Along with the
Digirad’s blog provides a variety of resources that keep you up to date on the ever-changing healthcare industry, including the advancements and issues that directly impact the operation of your practice. As we kick off a new year, here’s a look back at Digirad’s Top 5 Blog Posts from 2018:
PET/CT is a vital diagnostic imaging tool and is especially effective in revealing conditions such as cancer and brain disorders. When it comes to Medicare coverage, there are a number of misconceptions about PET/CT reimbursements. In the majority of cases, PET/CT imaging is covered when clinically necessary, either as an
The large majority of the nuclear imaging community would be quick to point out that PET/CT imaging with either 18Fluorodeoxyglucose (18FDG), or Sodium 18Fluoride (NaF18), is not effective in prostate cancer diagnosis. In fact, it’s not even approved for initial prostate treatment strategy. With oncology imaging, most other cancers are
Launched in 2015, the ASNC ImageGuide Registry is the first national registry developed to support non-invasive cardiac imaging and reduce the increasing regulatory reporting burden. It effectively promotes and ensures continuous quality improvement for referring physicians, technologists, and laboratories by improving efficiency, elevating the level of patient care, and reducing
Subscribe to the Digirad Newsletter for the latest updates.
©2020 Digirad Corporation. All rights reserved.